Evaluation of Ranibizumab and PDT for patients with pathologic myopia and macular CNV

Evaluation of Ranibizumab and PDT for patients with pathologic myopia and macular CNV

AIM: To evaluate the efficacy of anti- vascular endothelial growth factor(VEGF)and photodynamic therapy(PDT)on pathological myopia(PM)combined with choroidal neovascularization(CNV). <p>METHODS: Forty-three patients(45 eyes)diagnosed by fundus fluorescein angiography(FFA), indocyanine green an...

Full description

Bibliographic Details
Main Authors: Jing Yan, Chong Xu, Li Yan, Li-Ping Hu, Yan Zhao, Gui-Lan Luo, Jian-Hua Wu
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2018-02-01
Series:Guoji Yanke Zazhi
Subjects:
ETDRS chart
mean defect
pathological myopia
choroidal neovascularization
ranibizumab
photodynamic therapy
Online Access:http://www.ijo.cn/cn_publish/2018/3/201803022.pdf

Internet

http://www.ijo.cn/cn_publish/2018/3/201803022.pdf

Similar Items